» Authors » Thomas C Lauenstein

Thomas C Lauenstein

Explore the profile of Thomas C Lauenstein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 108
Citations 1498
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Schelhorn J, Best J, Reinboldt M, Gerken G, Ruhlmann M, Lauenstein T, et al.
J Vasc Interv Radiol . 2015 May; 26(7):972-9. PMID: 25937296
Purpose: To compare the utility of gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid (Gd-EOB-DTPA), a liver-specific magnetic resonance (MR) imaging contrast agent, versus gadobutrol for treatment response evaluation of hepatocellular carcinoma (HCC)...
12.
Schelhorn J, Richly H, Ruhlmann M, Lauenstein T, Theysohn J
Acta Radiol Open . 2015 Apr; 4(4):2047981615570417. PMID: 25922690
Background: Overall survival (OS) of patients with hepatic metastases of uveal melanoma is strongly linked with hepatic tumor control. Due to the lack of an effective systemic chemotherapy, locoregional therapies...
13.
Lazik A, Landgraeber S, Schulte P, Kraff O, Lauenstein T, Theysohn J
Skeletal Radiol . 2015 Mar; 44(7):941-51. PMID: 25805436
Objective: To evaluate the usefulness of the metal artifact reduction technique "WARP" in the assessment of metal-on-metal hip resurfacings at 1.5 and 3T in the context of image quality and...
14.
Lazik A, Korsmeier K, Classen T, Jager M, Kamminga M, Kraff O, et al.
J Magn Reson Imaging . 2014 Dec; 42(3):624-33. PMID: 25522716
Background: To evaluate the feasibility of 3 Tesla (T) high-resolution and gadolinium enhanced MRI of cartilage (dGEMRIC) in the thin and rounded hip cartilage of patients after acetabular matrix-based autologous...
15.
Schelhorn J, Best J, Reinboldt M, Dechene A, Gerken G, Ruhlmann M, et al.
J Magn Reson Imaging . 2014 Dec; 42(3):818-27. PMID: 25515676
Purpose: To investigate whether additional diffusion-weighted imaging (DWI) improves therapy response evaluation by Gd-EOB magnetic resonance imaging (MRI) in hepatocellular carcinoma (HCC) after radioembolization. Materials And Methods: Fifty patients with...
16.
Hahnemann M, Nensa F, Kinner S, Maderwald S, Umutlu L, Gerken G, et al.
Invest Radiol . 2014 Sep; 50(2):67-72. PMID: 25260093
Objectives: The objective of this study was to evaluate whether the use of automatically generated maps of bowel motility (motility mapping) in magnetic resonance imaging (MRI) leads to an increased...
17.
Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P, et al.
Eur J Nucl Med Mol Imaging . 2014 Sep; 42(1):56-65. PMID: 25223420
Purpose: To evaluate the diagnostic potential of PET/MRI with [(18)F]FDG in recurrent ovarian and cervical cancer in comparison to PET/CT. Methods: A group of 19 patients with suspected recurrence of...
18.
Sirin S, Kathemann S, Schweiger B, Hahnemann M, Forsting M, Lauenstein T, et al.
Invest Radiol . 2014 Sep; 50(1):32-9. PMID: 25215934
Objectives: Magnetic resonance colonography (MRC) is a well-accepted, noninvasive imaging modality for the depiction of inflammatory bowel disease. Diffusion-weighted imaging (DWI) is very helpful to display inflammatory lesions. The aim...
19.
Wetter A, Nensa F, Lipponer C, Guberina N, Olbricht T, Schenck M, et al.
Acta Radiol . 2014 Aug; 56(8):1009-15. PMID: 25168023
Background: Diffusion-weighted imaging (DWI) is routinely used in magnetic resonance imaging (MRI) of prostate cancer. However, the routine use of b values higher than 1000 s/mm(2) is not clear up...
20.
Wetter A, Nensa F, Schenck M, Heusch P, Poppel T, Bockisch A, et al.
PLoS One . 2014 Jul; 9(7):e101571. PMID: 25033396
Purpose: To characterize intermediate and high-risk prostate carcinomas with measurements of standardized uptake values (SUVs) and apparent diffusion coefficient (ADC) values by means of simultaneous [18F] choline PET/MRI. Materials And...